Blood Pressure Association with the 8-Item Morisky Medication Adherence Scale in Hypertensive Adults from Low-Resource Primary Care Settings: Results from a Prospective Cohort Nested within a Randomised Controlled Trial
- PMID: 37199879
- DOI: 10.1007/s40292-023-00580-7
Blood Pressure Association with the 8-Item Morisky Medication Adherence Scale in Hypertensive Adults from Low-Resource Primary Care Settings: Results from a Prospective Cohort Nested within a Randomised Controlled Trial
Abstract
Introduction: One of the self-report adherence scales most widely used is the 8-item Morisky Medication Adherence Scale (MMAS-8).
Aim: To evaluate construct validity and reliability of the MMAS-8 in hypertensive adults from low-resource settings within the public primary care level in Argentina.
Methods: Prospective data from hypertensive adults under antihypertensive pharmacological treatment that participated in the "Hypertension Control Program in Argentina" study was analyzed. Participants were followed at baseline, 6, 12 and 18 months. Based on MMAS-8, adherence was defined as low (score < 6), medium (score 6 to < 8) and high (score of 8).
Results: 1214 participants were included in the analysis. In comparison to low adherence, high adherence category was associated with a reduction of - 5.6 mmHg (CI 95%: - 7.2; - 4.0) in systolic blood pressure (BP) and - 3.2 mmHg (CI 95%: - 4.2; - 2.2) in diastolic BP; and with a 56% higher likelihood to have controlled BP (p < .0001). Among those participants with baseline score ≤ 6, two points increase in MMAS-8 along follow-up showed a tendency to reduce BP in almost all-time points and a 34% higher likelihood of having controlled BP at the end of the follow-up (p = 0.0039). Cronbach's alpha total-item values in all time-points were higher than 0.70.
Conclusions: Higher MMAS-8 categories were positively associated with BP reduction and higher likelihood of BP control over time. Internal consistency was acceptable and in line with previous studies.
Keywords: Blood pressure control; Hypertension; MMAS-8; Medication adherence.
© 2023. Italian Society of Hypertension.
Similar articles
-
Validation of the Persian Version of the 8-Item Morisky Medication Adherence Scale (MMAS-8) in Iranian Hypertensive Patients.Glob J Health Sci. 2015 Jan 1;7(4):173-83. doi: 10.5539/gjhs.v7n4p173. Glob J Health Sci. 2015. PMID: 25946926 Free PMC article.
-
Association between the 8-item Morisky Medication Adherence Scale (MMAS-8) and blood pressure control.Arq Bras Cardiol. 2012 Jul;99(1):649-58. doi: 10.1590/s0066-782x2012005000053. Epub 2012 Jun 7. Arq Bras Cardiol. 2012. PMID: 22688844 English, Portuguese.
-
The 8-item Morisky Medication Adherence Scale: validation of a Brazilian-Portuguese version in hypertensive adults.Res Social Adm Pharm. 2014 May-Jun;10(3):554-61. doi: 10.1016/j.sapharm.2013.10.006. Epub 2013 Oct 26. Res Social Adm Pharm. 2014. PMID: 24268603
-
Questionnaires on adherence to antihypertensive treatment: a systematic review of published questionnaires and their psychometric properties.Int J Clin Pharm. 2020 Apr;42(2):355-365. doi: 10.1007/s11096-020-00981-x. Epub 2020 Feb 5. Int J Clin Pharm. 2020. PMID: 32026354
-
Defining Meaningful Change in Antihypertensive Medication Adherence in Adults with Established Hypertension: Implications for Clinical Practice.Med Clin North Am. 2023 Nov;107(6S):e39-e52. doi: 10.1016/j.mcna.2023.06.008. Epub 2023 Jul 23. Med Clin North Am. 2023. PMID: 38609280 Free PMC article. Review.
Cited by
-
Adherence to Oral Hormonal Treatment among Breast Cancer Patients in Egypt.Asian Pac J Cancer Prev. 2024 Oct 1;25(10):3619-3625. doi: 10.31557/APJCP.2024.25.10.3619. Asian Pac J Cancer Prev. 2024. PMID: 39471029 Free PMC article.
-
Adherence to oral and topical medications among dermatology patients.Arch Dermatol Res. 2025 Mar 20;317(1):609. doi: 10.1007/s00403-025-03952-2. Arch Dermatol Res. 2025. PMID: 40111573
References
-
- Global Health Data Exchange GHDx. 2020. http://ghdx.healthdata.org/gbd-results-tool .
-
- Chow CK, Teo KK, Rangarajan S, Islam S, Gupta R, Avezum A, Bahonar A, Chifamba J, Dagenais G, Diaz R, Kazmi K, Lanas F, Wei L, Lopez-Jaramillo P, Fanghong L, Ismail NH, Puoane T, Rosengren A, Szuba A, Temizhan A, Wielgosz A, Yusuf R, Yusufali A, McKee M, Liu L, Mony P, Yusuf S, Investigators PS. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA. 2013;310(9):959–68. - DOI - PubMed
-
- Irazola VE, Gutierrez L, Bloomfield G, Carrillo-Larco RM, Dorairaj P, Gaziano T, Levitt NS, Miranda JJ, Ortiz AB, Steyn K, Wu Y, Xavier D, Yan LL, He J, Rubinstein A. Hypertension prevalence, awareness, treatment, and control in selected LMIC communities: results from the NHLBI/UHG network of centers of excellence for chronic diseases. Glob Heart. 2016;11(1):47–59. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical